| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.383 | 0.1 | 0.383 | Cyclophilin D inhibitor | |||
| 0.296 | 0.037 | 0.296 | EphB2 antagonist | |||
| 0.232 | 0.01 | 0.232 | Androgen antagonist | 0.203 0.013 DB15647 | ||
| 0.287 | 0.119 | 0.287 | Toll-Like receptor 7 agonist | |||
| 0.277 | 0.126 | 0.277 | Toll-Like receptor agonist | |||
| 0.237 | 0.121 | 0.273 | Ca(v)3.3 blocker | 0.273 0.069 DB15647 | DB15647 | |
| 0.118 | 0.015 | 0.146 | MAP kinase kinase 8 inhibitor | 0.146 0.01 DB15647 | DB15647 | |
| 0.135 | 0.041 | 0.135 | Nav1.4 sodium channel blocker | |||
| 0.123 | 0.059 | 0.123 | Glycogen synthase kinase-3 inhibitor | |||
| 0.105 | 0.071 | 0.105 | Cyclin-dependent kinase 5 inhibitor | |||
| 0.052 | 0.021 | 0.052 | Cathepsin L2 inhibitor | 0.041 0.028 DB15647 | ||
| 0.06 | 0.047 | 0.091 | Purinergic P2 antagonist | 0.091 0.026 DB15647 | DB15647 | |
| 0.064 | 0.052 | 0.064 | Nav1.7 sodium channel blocker | |||
| 0.083 | 0.086 | 0.12 | MAP kinase 8 inhibitor | 0.12 0.043 DB15647 | DB15647 | |
| 0.04 | 0.045 | 0.061 | Purinergic P2X antagonist | 0.061 0.022 DB15647 | DB15647 | |
| 0.029 | 0.035 | 0.041 | Purinergic P2X3 antagonist | 0.041 0.016 DB15647 | DB15647 | |
| 0.071 | 0.095 | 0.081 | Ca(v)3.1 blocker | 0.081 0.057 DB15647 | DB15647 | |
| 0.16 | 0.22 | 0.198 | Nootropic | 0.198 0.161 DB15647 | DB15647 | |
| 0.089 | 0.192 | 0.121 | Cyclin-dependent kinase 8 inhibitor | 0.121 0.116 DB15647 | DB15647 | |
| 0.105 | 0.469 | 0.352 | MAP kinase 1 inhibitor | 0.352 0.135 DB15647 | DB15647 | |
| 0.031 | 0.485 | 0.263 | Antimitotic | 0.263 0.055 DB15647 | DB15647 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |